Generics of Johnson & Johnson’s ADHD pill Concerta are hitting hard times due to an FDA crackdown on their bioequivalence. The agency said six months ago that generics makers Lannett and Mallinckrodt had that much time to confirm their extended-release technology matched that of J&J’s.
Plenty of drugmakers, including Shire and J&J, market ADHD drugs for children. But those drugs may not help kids do their homework or get better grades, a new study shows.
Highland Therapeutics, a Toronto-based company with delayed-release technology for ADHD treatment, is launching a Phase II study of its drug HLD100 designed for nighttime dosing of ADHD patients to improve their functioning when they wake.